Orol dengizi mintaqasidagi arterial gipertenziyaning molekulyar-genetik xususiyatlari

Qabul qilingan: 2025-01-27 12:14:41

Nashr etilgan: 2024-09-27

Annotatsiya

Maqsad. Arterial gipertenziya (AG) – bu murakkab, ko‘p omilli kasallik bo‘lib, yurak-qon tomir kasalliklariga katta hissa qo‘shadi. Ayniqsa, Orol dengizi mintaqasida bu kasallik juda keng tarqalgan bo‘lib, unda genetik va ekologik omillar muhim rol o‘ynaydi. Ushbu tadqiqot Orol dengizi mintaqasidagi AG kasalligining molekulyar-genetik xususiyatlarini o‘rganishga qaratilgan.


Materiallar va usullar. Tadqiqot Qoraqalpog‘iston Respublikasining Ellikkala tuman tibbiyot birlashmasining oilaviy poliklinikasida AG tashxisi qo‘yilgan 40-70 yoshdagi 1020 nafar bemorda o‘tkazildi. Genetik tahlil 407 nafar AG bemorida amalga oshirilib, gipertenziya bilan bog‘liq bo‘lgan asosiy genlarda polimorfizm mavjudligi aniqlangan.


Natijalar. AG bemorlarida uchta muhim genetik polimorfizm aniqlangan: AGTR2 genidagi G1675A polimorfizmi, ADD1 genidagi G460T polimorfizmi va AGT genidagi C704T polimorfizmi. Ushbu polimorfizmlar Orol dengizi mintaqasi aholisi orasida AG rivojlanishi bilan bog‘liq ekanligi aniqlandi.


Xulosa. Bu Orol dengizi mintaqasida AG bo‘yicha o‘tkazilgan birinchi keng miqyosli molekulyar- genetik tadqiqot bo‘lib, unda AGning yuqori tarqalishiga hissa qo‘shadigan genetik markerlar aniqlangan. Ushbu natijalar mintaqa aholisiga xos yurak-qon tomir kasalliklari uchun genetik xavf hisoblagichini ishlab chiqishda yordam beradi.

Adabiyotlar ro'yxati

  1. Kazantseva V.D., Peripartum cardiomyopathy: Pathophysiology and clinical aspects, Journal of Cardiovascular Research, 2021, 17, 05, 142–149.

  2. Honigberg M.C., Givertz M.M., Diagnosis and management of peripartum cardiomyopathy: A comprehensive review, European Heart Journal, 2019, 32, 022, 2173–2182.

  3. Iha N., Iha A.K., Role of echocardiography in peripartum cardiomyopathy, Journal of Cardiological Echocardiography, 2019, 16, 02, 58–62.

  4. Main E.K., McCain C.L., Morton C.H., Pregnancy-related mortality in California: Causes, characteristics, and improvement opportunities, Obstetrics Gynecology, 2015, 125, 938–947.

  5. The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC), Guidelines on the management of cardiovascular diseases during pregnancy, European Heart Journal, 2015, 32, 3147–3197.

  6. Duncker D., Westenfeld R., Konrad T., Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: A German multi-center analysis, Clinical Research in Cardiology, 2017, 106, 08, 582–589, 10.1007/s00392-017-1090-5.

  7. Abdullaev T.A., Tsoi I.A., Khudoyberganov O.K., Mirzarakhimova S.T., Five-year survival prognosis in patients with peripartum cardiomyopathy, Cardiological Herald, 2022, 17, 03, 58–62.

  8. Hilfiker Kleiner D., Haghikia A., Nonhoff J., Bauersachs J., Peripartum cardiomyopathy: Current management and future perspectives, European Heart Journal, 2015, 36, 018, 1090–1097, 10.1093/eurheartj/ehv009.

  9. Goland S., Elkayam U., Peripartum cardiomyopathy: Approach to management, Current Opinion in Cardiology, 2018, 33, 03, 347–353.

  10. Pillarisetti J., Kondur A., Alani A., Peripartum cardiomyopathy: Predictors of recovery and current state of implantable cardioverter-defibrillator use, Journal of the American College of Cardiology, 2014, 63, 025 Pt A, 2831–2839.

  11. Mallikethi Reddy S., Akintoye E., Trehan N., Burden of arrhythmias in peripartum cardiomyopathy: Analysis of 9841 hospitalizations, International Journal of Cardiology, 2017, 235, 114–117.

  12. Duncker D., Pfeffer T.J., Bauersachs J., Veltmann C., ECG and arrhythmias in peripartum cardiomyopathy, Herzschrittmachertherapie Elektrophysiologie, 2021, 32, 02, 207–213.

  13. Laghari A.H., Khan A.H., Kazmi K.A., Peripartum cardiomyopathy: Ten year experience at a tertiary care hospital in Pakistan, BMC Research Notes, 2015, 6, 495.

  14. Duncker D., Westenfeld R., Konrad T., Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: A German multi-centre analysis, Clinical Research in Cardiology, 2017, 106, 08, 582–589, 10.1007/s00392-017-1090-5.

  15. Abdullaev T.A., Khudoyberganov O.K., Mirzarakhimova S.T., Tsoi, I. A., Frequency and characteristics of arrhythmias and conduction disturbances in relation to the heart remodeling in patients with peripartum cardiomyopathy, Society and Innovation, 2022, 3, 134–141.

Mualliflar haqida

orcid
Xurshid X.Ataniyazov
Respublika ixtisoslashtirilgan kardiologiya ilmiy-amaliy tibbiyot markazining Qoraqalpog ’ iston mintaqaviy filiali
orcid
Xurshid G.Fozilov
Respublika ixtisoslashgan kardiologiya ilmiy-amaliy tibbiyot markazi
orcid
Gulnoz A.Хamidullaeva
Respublika ixtisoslashgan kardiologiya ilmiy-amaliy tibbiyot markazi
orcid
Guzal J.Abdullaeva
Respublika ixtisoslashtirilgan kardiologiya ilmiy-amaliy tibbiyot markazining Qoraqalpog ’ iston mintaqaviy filiali

Litsenziya

Mualliflik huquqi (c) 2024 X.Х. Атаниязов, Х.Г. Фозилов, Г.А. Хамидуллаева , Г.Ж. Абдуллаева (Автор)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Qanday iqtibos keltirish kerak

Orol dengizi mintaqasidagi arterial gipertenziyaning molekulyar-genetik xususiyatlari. (2024). O’ZBEKISTON KARDIOLOGIYASI, 1(3), 153-159. https://doi.org/10.70626/cardiouz-2024-1-00018

Ushbu muallif(lar)ning eng koʻp oʻqilgan maqolalari

O'xshash maqolalar

Siz ham ushbu maqola uchun {$ advancedSearchLink} olishingiz mumkin.

ISSN 3060-4850 (Print)